Trillium Asset Management’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-5,547
Closed -$332K 235
2017
Q3
$332K Sell
5,547
-85,066
-94% -$5.06M 0.02% 199
2017
Q2
$5.88M Sell
90,613
-17,982
-17% -$1.14M 0.35% 102
2017
Q1
$6.78M Sell
108,595
-12,038
-10% -$725K 0.43% 90
2016
Q4
$6.96M Sell
120,633
-50,178
-29% -$2.96M 0.46% 84
2016
Q3
$10.2M Sell
170,811
-3,939
-2% -$242K 0.65% 64
2016
Q2
$10.8M Buy
174,750
+36,520
+26% +$2.25M 0.72% 56
2016
Q1
$8.52M Buy
138,230
+2,782
+2% +$164K 0.57% 76
2015
Q4
$8.24M Buy
135,448
+3,523
+3% +$210K 0.56% 75
2015
Q3
$6.67M Buy
+131,925
New +$7.03M 0.47% 81

Other funds holding XRAY

Trillium Asset Management's XRAY Position: Q4 2017 in Review

Trillium Asset Management sold out of Dentsply Sirona (XRAY) in Q4 2017, closing a stake of 5,547 shares — an estimated $332K sold.

Trillium Asset Management first reported a position in XRAY in Q3 2015 and held it in 9 quarters. The position peaked at $10.8M in Q2 2016. 570 funds tracked by Wall St. Rank hold XRAY as of Q4 2017.

  • Trillium Asset Management reported no remaining Dentsply Sirona position as of Q4 2017 after selling out during the quarter.
  • Trillium Asset Management sold 5,547 Dentsply Sirona shares in Q4 2017, an estimated $332K.
  • Trillium Asset Management first reported a position in Dentsply Sirona in Q3 2015 and held it in 9 quarters.
  • Trillium Asset Management's Dentsply Sirona position peaked at $10.8M in Q2 2016.
  • 570 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2017.

Based on Trillium Asset Management's 13F filing for Q4 2017, filed 1 Feb 2018.